Logo image of QTNT

QUOTIENT LTD (QTNT) Stock Fundamental Analysis

NASDAQ:QTNT - Nasdaq - JE00BNNSZY03 - Common Stock - Currency: USD

0.38  +0.01 (+2.73%)

After market: 0.3593 -0.02 (-5.45%)

Fundamental Rating

1

Overall QTNT gets a fundamental rating of 1 out of 10. We evaluated QTNT against 187 industry peers in the Health Care Equipment & Supplies industry. QTNT has a bad profitability rating. Also its financial health evaluation is rather negative. QTNT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QTNT had negative earnings in the past year.
In the past year QTNT has reported a negative cash flow from operations.
In the past 5 years QTNT always reported negative net income.
QTNT had a negative operating cash flow in each of the past 5 years.
QTNT Yearly Net Income VS EBIT VS OCF VS FCFQTNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

QTNT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QTNT Yearly ROA, ROE, ROICQTNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 2K -2K -4K -6K

1.3 Margins

QTNT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QTNT Yearly Profit, Operating, Gross MarginsQTNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

QTNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
QTNT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, QTNT has a worse debt to assets ratio.
QTNT Yearly Shares OutstandingQTNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
QTNT Yearly Total Debt VS Total AssetsQTNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

QTNT has an Altman-Z score of -11.49. This is a bad value and indicates that QTNT is not financially healthy and even has some risk of bankruptcy.
QTNT has a worse Altman-Z score (-11.49) than 84.93% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.49
ROIC/WACCN/A
WACC8.48%
QTNT Yearly LT Debt VS Equity VS FCFQTNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 1.79 indicates that QTNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.79, QTNT is doing worse than 79.00% of the companies in the same industry.
A Quick Ratio of 1.36 indicates that QTNT should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.36, QTNT is not doing good in the industry: 74.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.36
QTNT Yearly Current Assets VS Current LiabilitesQTNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

QTNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.79%.
QTNT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.85%.
Measured over the past years, QTNT shows a quite strong growth in Revenue. The Revenue has been growing by 11.62% on average per year.
EPS 1Y (TTM)-11.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.09%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y9.76%
Revenue growth 5Y11.62%
Sales Q2Q%-6.45%

3.2 Future

QTNT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.78% yearly.
Based on estimates for the next years, QTNT will show a quite strong growth in Revenue. The Revenue will grow by 16.13% on average per year.
EPS Next Y44.75%
EPS Next 2Y31.45%
EPS Next 3Y16.98%
EPS Next 5Y14.78%
Revenue Next Year6.8%
Revenue Next 2Y21.99%
Revenue Next 3Y19.62%
Revenue Next 5Y16.13%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QTNT Yearly Revenue VS EstimatesQTNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
QTNT Yearly EPS VS EstimatesQTNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QTNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year QTNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTNT Price Earnings VS Forward Price EarningsQTNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTNT Per share dataQTNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40

4.3 Compensation for Growth

QTNT's earnings are expected to grow with 16.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.45%
EPS Next 3Y16.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QTNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUOTIENT LTD

NASDAQ:QTNT (12/30/2022, 10:53:31 PM)

After market: 0.3593 -0.02 (-5.45%)

0.38

+0.01 (+2.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2022-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner Change0%
Ins Owners71.36%
Ins Owner Change0%
Market Cap1.29M
Analysts85.71
Price Target61.2 (16005.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-212.08%
Min EPS beat(2)-229.77%
Max EPS beat(2)-194.39%
EPS beat(4)0
Avg EPS beat(4)-157.49%
Min EPS beat(4)-229.77%
Max EPS beat(4)-82.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.74%
Min Revenue beat(2)-21.78%
Max Revenue beat(2)-17.7%
Revenue beat(4)1
Avg Revenue beat(4)-11.06%
Min Revenue beat(4)-21.78%
Max Revenue beat(4)3.88%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-33.33%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3437.42%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-53.21
EYN/A
EPS(NY)-13.06
Fwd EYN/A
FCF(TTM)-37.36
FCFYN/A
OCF(TTM)-36.7
OCFYN/A
SpS11.08
BVpS-53.62
TBVpS-53.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.36
Altman-Z -11.49
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)41.7%
Cap/Depr(5y)74.02%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.09%
EPS Next Y44.75%
EPS Next 2Y31.45%
EPS Next 3Y16.98%
EPS Next 5Y14.78%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y9.76%
Revenue growth 5Y11.62%
Sales Q2Q%-6.45%
Revenue Next Year6.8%
Revenue Next 2Y21.99%
Revenue Next 3Y19.62%
Revenue Next 5Y16.13%
EBIT growth 1Y-27.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.41%
EBIT Next 3Y12.08%
EBIT Next 5Y4.76%
FCF growth 1Y-74.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.8%
OCF growth 3YN/A
OCF growth 5YN/A